RxSight, Inc. (RXST) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Rxsight, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.616 Gentlemen, thank you for standing by. My name is Desiree and I will be your conference 00:00:03.616 -- 00:00:08.523 operator today. At this time, I would like to welcome everyone to the RxSight Second 00:00:08.523 -- 00:00:13.290 Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent 00:00:13.290 -- 00:00:17.616 any background noise. After the speaker's remarks, there will be a question and answer 00:00:17.616 -- 00:00:22.923 session. If you would like to ask a question during this time, simply press star 00:00:22.923 -- 00:00:25.527 followed by the number one on your telephone keypad. 00:00:25.527 -- 00:00:29.360 If you would like to withdraw your question again, press the star one. 00:00:29.360 -- 00:00:34.385 I would now like to turn the conference over to Oliver Moravchevich, Vice President of 00:00:34.385 -- 00:00:36.087 Investor Relations. You may begin. 00:00:36.087 -- 00:00:37.789 Thank 00:00:37.789 -- 00:00:42.895 you, Operator. Presenting today are RxSight President and Chief Executive Officer, Dr. 00:00:42.895 -- 00:00:46.319 Ron Kurtz, and Chief Financial Officer, Shelley Tunin. 00:00:46.319 -- 00:00:50.883 Earlier today, RxSight released its financial results for the three months ending June 00:00:50.883 -- 00:00:52.726 30, 2025, 00:00:52.726 -- 00:00:57.771 and reiterated its full-year guidance. A copy of the press release is available on the 00:00:57.771 -- 00:01:02.955 company's website. Before we begin, I would like to inform you that comments and responses 00:01:02.955 -- 00:01:08.881 to questions during today's call reflect management's view as of today, August 7, 2025, 00:01:08.881 -- 00:01:13.607 and will include forward-looking and opinion statements, including predictions, estima...